Economic pressures are closely linked to political pressures but also have their distinct characteristics. Budget constraints can limit the scope of epidemiological research and interventions. For example, during a recession, there might be cuts in public health funding, leading to reduced surveillance and control measures.
Additionally, the economic interests of pharmaceutical companies and other stakeholders can impact epidemiological research. There may be a tendency to focus on diseases that promise higher financial returns, neglecting those that predominantly affect poorer populations.
